Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI

Journal of Neuroscience

Volumn 22, Issue 21, 2002, Pages 9635-9642

  Zhang, Yahong ^a   Damjanoska, Katerina J ^a   Carrasco, Gonzalo A ^a   Dudas, Bertalan ^a   D'Souza, Deborah N ^a   Tetzlaff, Julie ^a   Garcia, Francisca ^a   Sullivan Hanley, Nicole R ^a   Scripathirathan, Kumar ^a   Petersen, Brett R ^a   Gray, Thackery S ^a   Battaglia, George ^a   Muma, Nancy A ^a   Van de Kar, Louis D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

ACTH; Corticosterone; MDL100,907; Oxytocin; Prolactin; PVN; Renin; Serotonin

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CORTICOSTERONE; CORTICOTROPIN; OXYTOCIN; PROLACTIN; RENIN; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; FLUOROBENZENE; PIPERIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTION; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEROTONINERGIC SYSTEM; THALAMUS MIDLINE NUCLEUS; ANIMAL; ANTERIOR HYPOTHALAMUS; BLOOD; CYTOLOGY; DRUG EFFECT; METABOLISM; NEUROSECRETION; SPRAGUE DAWLEY RAT;

ADRENOCORTICOTROPIC HORMONE; AMPHETAMINES; ANIMALS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTIONS; NEUROSECRETORY SYSTEMS; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PIPERIDINES; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RENIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0036827036     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-21-09635.2002     Document Type: Article

References (57)

1. Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: Emerging role of glutamate mechanisms. Brain Res Rev 31:302-312.
2. Alper RH (1990) Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology 51:255-260.
3. 1c receptors in rat brain. J Pharmacol Exp Ther 255:843-857.
4. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses: Behav Brain Res 73:277-280.
5. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology 134:1127-1131.
6. Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664-2669.
7. Bailey TW, DiMicco JA (2001) Chemical stimulation of the dorsomedial hypothalamus elevates plasma ACTH in conscious rats. Am J Physiol Regul Integr Comp Physiol 280:R8-R15.
8. Barden N, Reul JMHM, Holsboer F (1995) Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system. Trends Neurosci 18:6-11.
9. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
10. Beaulieu S, DiPaolo T, Barden N (1986) Control of ACTH secretion by the central nucleus of the amygdala: Implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism. Neuroendocrinology 44:247-254.
11. Berg KA, Stout BD, Maayani S, Clarke WP (2001) Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation. J Pharmacol Exp Ther 299:593-602.
12. Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, Falkai P, Bogerts B (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83:867-875.
13. Blier P, de Montigny C (1999) Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21:91S-98S.
14. Cornea-Hébert V, Riad M, Wu C, Singh SK, Descarries L (1999) Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409:187-209.
15. Feldman S, Newman ME, Gur E, Weidenfeld J (1998) Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses. NeuroReport 9:2007-2009.
16. Fritschy JM, Weinmann O, Wenzel A, Benke D (1998) Synapse-specific localization of NMDA and GABA(A) receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 390:194-210.
17. Gundlah C, Pecins-Thompson M, Schutzer WE, Bethea CL (1999) Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res Mol Brain Res 63:325-339.
18. 2A receptor mediation of the HPA axis. Neuropharmacology 42:162-169.
19. Herman JP, Cullinan WE (1997) Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84.
20. Hoffman BJ, Mezey E (1989) Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett 247:453-462.
21. 2A receptor antagonist MDL 100, 907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15:116-124.
22. 2C receptor antagonist. Neuropharmacology 36:609-620.
23. Kozuru T, Kagaya A, Takebayashi M, Horiguchi J, Yamawaki S (2000) Chronic electroconvulsive shock decreases (±)1-(4-iodo-2, 5-dimethoxyphenyl)-2-aminopropane hydrochloride (DOI)-induced wet-dog shake behaviors of dexamethasone-treated rats. Life Sci 66:1271-1279.
24. Legros JJ (1992) Neurohypophyseal peptides and psychopathology. Horm Res 37 [Suppl 3]:16-21.
25. 1A agonist, 8-OH-DPAT. Neuropharmacology 33:335-342.
26. 2 antagonist. Mol Pharmacol 27:600-611.
27. Li Q, Brownfield MS, Battaglia G, Cabrera TM, Levy AD, Rittenhouse PA, Van de Kar LD (1993) Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (±)-1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane HCI (DOI). J Pharmacol Exp Ther 266:836-844.
28. 1A receptors. J Pharmacol Exp Ther 282:1581-1590.
29. Liposits Z, Phelix C, Paull WK (1987) Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86:541-549.
30. Martin GR, Humphrey PPA (1994) Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 33:261-273.
31. McCall RB, Harris LT (1988) 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge. Eur J Pharmacol 151:113-116.
32. Petrov T, Krukoff TL, Jhamandas JH (1994) Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 277:289-295.
33. Price LH, Malison RT, Mcdougle CJ, McCance-Katz EF, Owen KR, Heninger GR (1997) Neurobiology of tryptophan depletion in depression: Effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharmacology 17:342-350.
34. Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF (1996) Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 53:137-143.
35. Richardson Morton KD, Van de Kar LD, Brownfield MS, Bethea CL (1989) Neuronal cell bodies in the hypothalamic paraventricular nucleus mediate stress-induced renin and corticosterone secretion. Neuroendocrinology 50:73-80.
36. Rittenhouse PA, Li Q, Levy AD, Van de Kar LD (1992) Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of renin secretion. Brain Res 593:105-113.
37. 1C/2 receptors. Endocrinology 133:661-667.
38. 2A/2C) receptors. J Pharmacol Exp Ther 271:1647-1655.
39. Saphier D, Feldman S (1986) Electrophysiology of limbic forebrain and paraventricular nucleus connections. Brain Res Bull 17:743-750.
40. Sargent PA, Quested DJ, Cowen PJ (1998) Clomipramine enhances the cortisol response to 5-HTP: Implications for the therapeutic role of 5-HT2 receptors. Psychopharmacology 140:120-122.
41. Sawchenko PE, Swanson LW (1985) Localization, colocalization and plasticity of corticotropin- releasing factor immunoreactivity in rat brain. Fed Proc 44:221-227.
42. Scott LV, Dinan TG (1998) Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: Implications for the pathophysiology of depression. Life Sci 62:1985-1998.
43. Sherman BM, Pfohl B (1985) Rhythm-related changes in pituitary-adrenal function in depression. J Affect Disord 9:55-61.
44. Stotz-Potter EH, Morin SM, DiMicco JA (1996) Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air stress-induced neuroendocrine and cardiovascular changes in rats. Brain Res 742:219-224.
45. Swanson LW (1992) Brain Maps: Structure of the Rat Brain, pp 22, 25-27. Amsterdam: Elsevier.
46. Swanson LW, Sawchenko PE (1983) Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6:269-324.
47. Urban JH, Brownfield MS, Levine JE, Van de Kar LD (1992) Distribution of a renin-releasing factor in the central nervous system of the rat. Neuroendocrinology 55:574-582.
48. Van de Kar LD, Blair ML (1999) Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol 20:1-48.
49. Van de Kar LD, Urban JH, Brownfield MS, Simmons WH (1987) Partial characterization of a renin-releasing factor from plasma and hypothalamus. Hypertension 9:598-606.
50. Van de Kar LD, Rittenhouse PA, Li Q, Levy AD (1995a) Serotonergic regulation of renin and prolactin secretion. Behav Brain Res 73:203-208.
51. Van de Kar LD, Rittenhouse PA, Li Q, Levy AD, Brownfield MS (1995b) Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res Bull 36:45-50.
52. 2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 21:3572-3579.
53. Van Wijngaarden I, Tulp MTM, Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 188:301-312.
54. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27:79-82.
55. 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351:357-373.
56. 2A serotonin receptors on oxytocin cells in the hypothalamic paraventricular nucleus. Soc Neurosci Abstr 27:265-12
57. Zifa E, Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401-458.